These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29523787)

  • 1. Paracrine cellular senescence exacerbates biliary injury and impairs regeneration.
    Ferreira-Gonzalez S; Lu WY; Raven A; Dwyer B; Man TY; O'Duibhir E; Lewis PJS; Campana L; Kendall TJ; Bird TG; Tarrats N; Acosta JC; Boulter L; Forbes SJ
    Nat Commun; 2018 Mar; 9(1):1020. PubMed ID: 29523787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic cholestatic liver diseases: clues from histopathology for pathogenesis.
    Pollheimer MJ; Fickert P; Stieger B
    Mol Aspects Med; 2014 Jun; 37():35-56. PubMed ID: 24141039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2
    Zhou T; Wu N; Meng F; Venter J; Giang TK; Francis H; Kyritsi K; Wu C; Franchitto A; Alvaro D; Marzioni M; Onori P; Mancinelli R; Gaudio E; Glaser S; Alpini G
    Lab Invest; 2018 Nov; 98(11):1449-1464. PubMed ID: 29977037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracrine modulation of cholangiocyte serotonin synthesis orchestrates biliary remodeling in adults.
    Omenetti A; Yang L; Gainetdinov RR; Guy CD; Choi SS; Chen W; Caron MG; Diehl AM
    Am J Physiol Gastrointest Liver Physiol; 2011 Feb; 300(2):G303-15. PubMed ID: 21071507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy mediates the process of cellular senescence characterizing bile duct damages in primary biliary cirrhosis.
    Sasaki M; Miyakoshi M; Sato Y; Nakanuma Y
    Lab Invest; 2010 Jun; 90(6):835-43. PubMed ID: 20212459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target.
    Trussoni CE; O'Hara SP; LaRusso NF
    Semin Immunopathol; 2022 Jul; 44(4):527-544. PubMed ID: 35178659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence.
    Bird TG; Müller M; Boulter L; Vincent DF; Ridgway RA; Lopez-Guadamillas E; Lu WY; Jamieson T; Govaere O; Campbell AD; Ferreira-Gonzalez S; Cole AM; Hay T; Simpson KJ; Clark W; Hedley A; Clarke M; Gentaz P; Nixon C; Bryce S; Kiourtis C; Sprangers J; Nibbs RJB; Van Rooijen N; Bartholin L; McGreal SR; Apte U; Barry ST; Iredale JP; Clarke AR; Serrano M; Roskams TA; Sansom OJ; Forbes SJ
    Sci Transl Med; 2018 Aug; 10(454):. PubMed ID: 30111642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of cholangioids from normal and diseased human cholangiocytes as an in vitro model to study primary sclerosing cholangitis.
    Loarca L; De Assuncao TM; Jalan-Sakrikar N; Bronk S; Krishnan A; Huang B; Morton L; Trussoni C; Bonilla LM; Krueger E; O'Hara S; Splinter P; Shi G; Pisarello MJL; Gores GJ; Huebert RC; LaRusso NF
    Lab Invest; 2017 Nov; 97(11):1385-1396. PubMed ID: 28892096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockout of the Tachykinin Receptor 1 in the Mdr2
    Ceci L; Francis H; Zhou T; Giang T; Yang Z; Meng F; Wu N; Kennedy L; Kyritsi K; Meadows V; Wu C; Liangpunsakul S; Franchitto A; Sybenga A; Ekser B; Mancinelli R; Onori P; Gaudio E; Glaser S; Alpini G
    Am J Pathol; 2020 Nov; 190(11):2251-2266. PubMed ID: 32712019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Secretin/Secretin Receptor Axis Modulates Ductular Reaction and Liver Fibrosis through Changes in Transforming Growth Factor-β1-Mediated Biliary Senescence.
    Wu N; Meng F; Zhou T; Venter J; Giang TK; Kyritsi K; Wu C; Alvaro D; Onori P; Mancinelli R; Gaudio E; Francis H; Alpini G; Glaser S; Franchitto A
    Am J Pathol; 2018 Oct; 188(10):2264-2280. PubMed ID: 30036520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic progenitor cells of biliary origin with liver repopulation capacity.
    Lu WY; Bird TG; Boulter L; Tsuchiya A; Cole AM; Hay T; Guest RV; Wojtacha D; Man TY; Mackinnon A; Ridgway RA; Kendall T; Williams MJ; Jamieson T; Raven A; Hay DC; Iredale JP; Clarke AR; Sansom OJ; Forbes SJ
    Nat Cell Biol; 2015 Aug; 17(8):971-983. PubMed ID: 26192438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional role of cellular senescence in biliary injury.
    Meng L; Quezada M; Levine P; Han Y; McDaniel K; Zhou T; Lin E; Glaser S; Meng F; Francis H; Alpini G
    Am J Pathol; 2015 Mar; 185(3):602-9. PubMed ID: 25619959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the management of cholestatic liver diseases.
    Appanna G; Kallis Y
    Clin Med (Lond); 2020 Sep; 20(5):513-516. PubMed ID: 32934048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2
    Moncsek A; Al-Suraih MS; Trussoni CE; O'Hara SP; Splinter PL; Zuber C; Patsenker E; Valli PV; Fingas CD; Weber A; Zhu Y; Tchkonia T; Kirkland JL; Gores GJ; Müllhaupt B; LaRusso NF; Mertens JC
    Hepatology; 2018 Jan; 67(1):247-259. PubMed ID: 28802066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
    Pollheimer MJ; Racedo S; Mikels-Vigdal A; Marshall D; Bowlus C; Lackner C; Madl T; Karlsen TH; Hov JR; Lyman SK; Adamkewicz J; Smith V; Moreau E; Zollner G; Eide TJ; Stojakovic T; Scharnagl H; Gruber HJ; Stauber RE; Trauner M; Fickert P
    J Hepatol; 2018 Aug; 69(2):368-377. PubMed ID: 29709678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in mice‡.
    McDaniel K; Meng F; Wu N; Sato K; Venter J; Bernuzzi F; Invernizzi P; Zhou T; Kyritsi K; Wan Y; Huang Q; Onori P; Francis H; Gaudio E; Glaser S; Alpini G
    Hepatology; 2017 Feb; 65(2):544-559. PubMed ID: 27639079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2
    Meadows V; Kennedy L; Hargrove L; Demieville J; Meng F; Virani S; Reinhart E; Kyritsi K; Invernizzi P; Yang Z; Wu N; Liangpunsakul S; Alpini G; Francis H
    Biochim Biophys Acta Mol Basis Dis; 2019 Dec; 1865(12):165557. PubMed ID: 31521820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction.
    Chen Y; Guldiken N; Spurny M; Mohammed HH; Haybaeck J; Pollheimer MJ; Fickert P; Gassler N; Jeon MK; Trautwein C; Strnad P
    J Pathol; 2015 Nov; 237(3):343-54. PubMed ID: 26108453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.
    Elßner C; Goeppert B; Longerich T; Scherr AL; Stindt J; Nanduri LK; Rupp C; Kather JN; Schmitt N; Kautz N; Breuhahn K; Ismail L; Heide D; Hetzer J; García-Beccaria M; Hövelmeyer N; Waisman A; Urbanik T; Mueller S; Gdynia G; Banales JM; Roessler S; Schirmacher P; Jäger D; Schölch S; Keitel V; Heikenwalder M; Schulze-Bergkamen H; Köhler BC
    Gastroenterology; 2019 Mar; 156(4):1190-1205.e14. PubMed ID: 30445013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.